OncoSynergy
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $20M
Investors
- 3
About OncoSynergy
OncoSynergy, Inc.OncoSynergy, Inc. was founded in 2011 and is headquartered in South San Francisco, US.OncoSynergy specializes in developing next-generation immunotherapies, with a primary focus on the investigational drug OS2966. This therapeutic antibody is designed to inhibit a cell surface receptor that plays a crucial role in the growth, spread, and treatment resistance of cancer, specifically targeting recurrent and progressive high-grade glioma (HGG). By utilizing convection-enhanced delivery (CED), OS2966 is administered directly into the brain, overcoming the challenges posed by the blood-brain barrier. The company’s approach addresses critical unmet needs in the treatment of HGG, providing a novel therapeutic option for patients requiring surgical resection.OncoSynergy's revenue model is primarily based on the advancement of its clinical-stage immunotherapy products, notably OS2966. The company engages in strategic partnerships and collaborations with clinical research organizations to facilitate its drug development process. Revenue generation is expected through collaborations with healthcare institutions and pharmaceutical companies aiming to explore the therapeutic potential of its offerings in clinical settings. The company aims to introduce new products within its immunotherapy portfolio as clinical data emerges, with specific timelines dependent on regulatory approvals. Additionally, OncoSynergy is looking to expand its market presence in Europe as clinical trials progress, enhancing its reach beyond the United States to address broader patient needs.
Who invested in OncoSynergy
3 investors across 1 round
See all investors in OncoSynergy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 30, 2018
Amount
$20M
Investors
Questions about OncoSynergy
Who invested in OncoSynergy?
OncoSynergy has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoSynergy raised?
OncoSynergy has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OncoSynergy last raise money?
OncoSynergy's most recent round on record is a Series A, in Apr 2018.
What does OncoSynergy do?
OncoSynergy is a biotechnology company.
Where is OncoSynergy headquartered?
OncoSynergy is headquartered in South San Francisco, US.
Which VCs invest in companies like OncoSynergy?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OncoSynergy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like OncoSynergy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.